
DiFusion Technologies announced issuance of US Patent No. 12,178,936 B2, Medical Implants and Methods of Manufacture. The new patent is encompasses four methods to manufacture ZFUZE, a proprietary therapeutic, anti-inflammatory, osseoconductive, load bearing biomaterial for orthopedic implants.
ZFUZE is reported to be the first FDA-cleared advanced biomaterial for spinal implants that is proven to create a highly favorable cellular and immunologic response post-surgery. Results from a 75-patient retrospective study indicate that ZFUZE posted a dominant 93.4% lumbar spinal fusion rate at 6 months, while similar competitive studies demonstrate average lumbar fusion rates of 68% at 12 months.
Source: DiFusion Inc.
DiFusion Technologies announced issuance of US Patent No. 12,178,936 B2, Medical Implants and Methods of Manufacture. The new patent is encompasses four methods to manufacture ZFUZE, a proprietary therapeutic, anti-inflammatory, osseoconductive, load bearing biomaterial for orthopedic implants.
ZFUZE is reported to be the first FDA-cleared...
DiFusion Technologies announced issuance of US Patent No. 12,178,936 B2, Medical Implants and Methods of Manufacture. The new patent is encompasses four methods to manufacture ZFUZE, a proprietary therapeutic, anti-inflammatory, osseoconductive, load bearing biomaterial for orthopedic implants.
ZFUZE is reported to be the first FDA-cleared advanced biomaterial for spinal implants that is proven to create a highly favorable cellular and immunologic response post-surgery. Results from a 75-patient retrospective study indicate that ZFUZE posted a dominant 93.4% lumbar spinal fusion rate at 6 months, while similar competitive studies demonstrate average lumbar fusion rates of 68% at 12 months.
Source: DiFusion Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.